Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 938 000 KRW -1.16% Market Closed
Market Cap: 66.8T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

34.3
Current
39.8
Median
18.5
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
34.3
=
Enterprise Value
66.4T KRW
/
EBITDA
1.9T KRW
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
36.2
2-Years Forward
EV/EBITDA
31
3-Years Forward
EV/EBITDA
26.4

See Also

Discover More